Genentech, Inc.

États‑Unis d’Amérique


 
Quantité totale PI 3 886
Quantité totale incluant filiales 3 932 (+ 46 pour les filiales)
Rang # Quantité totale PI 294
Note d'activité PI 4/5.0    2 377
Rang # Activité PI 282
Activité incl filiales 3,7/5.0    2 415
Parent Roche Holding AG
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

1 559 204
452 19
1 629 7
16
 
Dernier brevet 2025 - Diagnostic and therapeutic metho...
Premier brevet 1978 - Synthetic dna and method therefor
Dernière marque 2024 - IMRASGO
Première marque 1983 - GENENTECH

Filiales

2 subsidiaries with IP (15 patents, 31 trademarks)

1 subsidiaries without IP

 S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 P/S Pharmaceutical preparations for use in oncology
P/S Pharmaceutical preparations for use in neuroscience
P/S Pharmaceutical preparations for use in immunology
P/S Pharmaceutical preparations for use in oncology, neurology and immunology
P/S Pharmaceutical preparations for use in immunology; Pharmaceutical preparations for the treatment ...
P/S Pharmaceutical preparations for the treatment of metabolic diseases and disorders, Pharmaceutical...
P/S Pharmaceutical preparations for the prevention and treatment of neurological diseases
P/S Pharmaceutical preparations for use in the treatment of neurological conditions including Alzheimer
P/S Pharmaceutical preparations for use in the treatment of neurological conditions including Alzheimer.
Invention Diagnostic and therapeutic methods for cancer. Provided herein are diagnostic and therapeutic me...
Invention Machine learning enabled diagnosis and lesion localization for nascent geographic atrophy in age-...
P/S Pharmaceutical preparations for use in ophthalmology
P/S Pharmaceutical preparations for use in ophthalmology.
Invention Biomarkers and methods of treating pd-1 and pd-l1 related conditions. Provided herein are biomar...
Invention Hepatocellular carcinoma molecular subtype classification and subtype specific treatments for hep...
Invention Machine learning enabled hepatocellular carcinoma molecular subtype classification. A method for...
Invention Cell classification using center emphasis of a feature map. Techniques described herein include,...
Invention Methods of purifying polypeptides. The present invention provides methods for purifying a polype...
Invention Therapeutic compounds and methods of use thereof. The invention provides a compound of formula (...
Invention Anomaly detection in medical imaging data. Particular embodiments provide a method for anomaly d...
Invention Pathological response calculation and assessment tool. In one embodiment, a method includes, for...
Invention Incision guide tool for ocular device implantation and methods of use. A device configured to gu...
Invention Adjuvant treatment of her2-positive breast cancer. Methods are provided for the adjuvant treatme...
P/S Electronic data collection for business purposes in the medical field. Downloadable and recorded ...
Invention Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases. Disclo...
Invention Tetracyclic oxazepine compounds and uses thereof. Provided herein are tetracyclic oxazepinyl com...
Invention Pharmaceutical asset tracking. Pharmaceutical asset tracking systems and methods for pharmaceuti...
Invention Random heteropolymer excipients for high protein concentration formulations. This application re...
P/S Education, namely providing training in the field of oncology Medical services, namely, providing...
Invention Processes for the preparation of phenyltetrahydrofuran compounds. Provided are phenyltetrahydrof...
P/S Ophthalmological apparatus and instruments Education, namely providing training in the field of o...
Invention Methods for soft landing of macromolecules. inter aliainter alia, includes methods for performing...
Invention Pharmaceutical formulation comprising a coated tablet. The invention relates to pharmaceutical fo...
Invention Enhanced septum retention for implanted ocular delivery systems. An ophthalmic drug delivery devi...
Invention Lubricated fluid exchange needle for enhanced performance of refillable implantable ocular drug d...
Invention New uses of omalizumab. 150mg/mL omalizumab formulation for use in a method of treatment of one o...
Invention Diagnostic and therapeutic methods for cancer. Provided herein are diagnostic and therapeutic met...
P/S Downloadable software in the nature of a mobile application for acting as an information platform...
Invention Process for synthesis of quinazoline compounds. Provided herein are methods to synthesize compou...
P/S Pharmaceutical preparations for use in oncology and hematology
Invention Compositions and methods for treating multiple sclerosis. The present invention relates to method...
Invention Anti-ige antibody therapy for multiple food allergies. The present disclosure provides methods a...
Invention System and method for cell-of-origin classification based on interpretable cellular features. A m...
Invention Inhibitory rna targeting huntingtin expression. The present invention features RNA polynucleotide...
Invention Methods for treatment of cancer with an anti-tigit antagonist antibody. The present invention re...
Invention Multispecific antigen-binding proteins. Provided are, inter alia, multispecific antigen binding ...
Invention Machine learning enabled region-specific lesion segmentation. A method may include determining, w...
Invention Antibodies and uses thereof. Provided herein are antibodies such as human or humanized antibodie...
Invention In situ detection of barcodes. in situin situ. Advantageously, the method can be effectively used...
Invention Antibodies and uses thereof. Provided herein are antibodies such as human or humanized antibodies...
Invention Fused ring compounds. This invention pertains to fused ring compounds of Formula (I), as further...
Invention Method and apparatus for using omalizumab. A method of treating a patient with of one or more of...
Invention Synthesis of a bis-mesylate salt of 4-amino-n-(1-((3-chloro-2-fluorophenyl)amino)-6-methylisoquin...
Invention Production of heteromultimeric proteins using mammalian cells. Described herein are methods for ...
Invention High-concentration monoclonal antibody formulations. The present application discloses high-conc...
P/S Pharmaceutical preparations for the prevention and treatment of neurological and neurodegenerativ...
P/S Pharmaceutical ophthalmic preparations
Invention Antibodies and methods of use. The presently disclosed subject matter provides antibodies that b...
Invention Pharmaceutical compositions comprising akt protein kinase inhibitors. The present invention rela...
P/S Scientific laboratory services; providing scientific research information in the field of ophthal...
Invention High dose treatments for alzheimer's disease. Methods of treating Alzheimer's Disease (AD) in pa...
P/S Downloadable computer software for monitoring manufacturing processes in the pharmaceutical industry
2023 P/S Downloadable computer software in the field of health care and medicine, namely for screening and...
P/S Pharmaceutical preparations for the treatment of immune diseases and disorders and inflammatory d...
P/S Downloadable computer software for use in data collection, data processing and database managemen...
Invention Anti-ige antibody therapy for multiple food allergies. The present disclosure provides methods an...
P/S Downloadable computer software for use in database management in the field of health care and med...
Invention Methods for treatment of liver cancer. The present invention relates to the treatment of liver ca...
2022 Invention Cellular assays and methods to assess mhc-peptide-tcr interactions and kinetics. Compositions, s...
Invention Brm degrading compounds and associated methods of use. The present disclosure relates to bifunct...
Invention Cyclopentylpyrazole cdk2 inhibitors. Described here are compounds of Formula (I) and pharmaceuti...